Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

CAR t patients monitored for years in new Follow-Up study

NCT ID NCT06508775

First seen Nov 01, 2025 · Last updated Apr 30, 2026 · Updated 21 times

Summary

This study follows 40 people who received Miltenyi CAR T cell therapy at least one year ago for cancers like melanoma and leukemia. Researchers will track late side effects, infections, and disease relapse to understand long-term safety. Participants do not receive new treatment but provide health updates over time.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for PEDIATRIC ALL are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Charité Universitätsmedizin Berlin

    RECRUITING

    Berlin, 13353, Germany

  • Uniklinikum Erlangen

    ACTIVE_NOT_RECRUITING

    Erlangen, 91054, Germany

  • Universitäts-Kinderklinik Würzburg

    ACTIVE_NOT_RECRUITING

    Würzburg, 97080, Germany

  • Universitätsklinikum Köln

    ACTIVE_NOT_RECRUITING

    Cologne, 50937, Germany

  • Universitätsklinikum Münster

    RECRUITING

    Münster, 48149, Germany

  • Universitätsklinikum Tübingen

    ACTIVE_NOT_RECRUITING

    Tübingen, 72076, Germany

  • Universitätsmedizin Göttingen

    ACTIVE_NOT_RECRUITING

    Göttingen, 37075, Germany

Conditions

Explore the condition pages connected to this study.